Effect of multiple-dose erythromycin on everolimus pharmacokinetics.

Abstract:

OBJECTIVE:We sought to quantify the influence of the CYP3A inhibitor erythromycin on the pharmacokinetics of everolimus, a CYP3A substrate. METHODS:This was a two-period, single-sequence, crossover study in 16 healthy subjects. In period 1, subjects received the reference treatment of a single 2-mg dose of everolimus. In period 2, they received the test treatment of erythromycin 500 mg three times daily for a total of 9 days and a single 2-mg dose of everolimus coadministered on the fifth day of erythromycin therapy. The test/reference ratio and 90% confidence interval (CI) were derived for everolimus C (max) and AUC. RESULTS:During erythromycin coadministration, everolimus C (max) increased 2.0-fold (90% CI, 1.8-2.3) from 20+/-5 ng/ml to 40+/-10 ng/ml. Everolimus AUC increased 4.4-fold (90% CI, 3.5-5.4) from 116+/-37 ng h/ml to 524+/-225 ng h/ml. Everolimus half-life was prolonged by 39% from 32+/-6 h to 44+/-6 h. Erythromycin predose concentrations were not changed after single-dose administration of everolimus. CONCLUSION:Multiple-dose erythromycin increased single-dose everolimus blood levels by an average 4.4-fold (range, 2.0-12.6). During erythromycin treatment, a compensatory everolimus dose reduction should be made guided by everolimus therapeutic drug monitoring.

journal_name

Eur J Clin Pharmacol

authors

Kovarik JM,Beyer D,Bizot MN,Jiang Q,Shenouda M,Schmouder RL

doi

10.1007/s00228-004-0866-5

subject

Has Abstract

pub_date

2005-03-01 00:00:00

pages

35-8

issue

1

eissn

0031-6970

issn

1432-1041

journal_volume

61

pub_type

临床试验,杂志文章
  • The pharmacokinetics of clonidine in high dosage.

    abstract::We have evaluated the pharmacokinetics of high doses of clonidine, as used in the prophylactic treatment of alcohol withdrawal syndrome, in 11 alcohol-dependent patients undergoing surgery for oesophagogastrectomy. Clonidine was given in a bolus of 150 micrograms followed by a continuous infusion. After a mean period ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00315500

    authors: Fauler J,Verner L

    更新日期:1993-01-01 00:00:00

  • Pharmacokinetics and pharmacodynamics of controlled-release metoprolol: a comparison with atenolol.

    abstract::Pharmacokinetic and pharmacodynamic properties of a new controlled-release (CR) formulation of metoprolol have been compared with those of atenolol. Metoprolol CR (100 mg and 200 mg), atenolol (50 mg and 100 mg) and placebo were each given once daily for four days in a double-blind, cross-over study to ten healthy men...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/BF00578408

    authors: Blomqvist I,Westergren G,Sandberg A,Jonsson UE,Lundborg P

    更新日期:1988-01-01 00:00:00

  • Use of fixed doses of beta blocking drugs in the treatment of hypertension. Randomised study of atenolol and penbutolol.

    abstract::Atenolol 100 mg and penbutolol 40 mg given once a day were both effective in controlling moderate hypertension, as judged by a randomised controlled, double-blind trial in 45 patients treated for six weeks. Both drugs significantly reduced the resting supine and erect blood pressures. No serious adverse effects could ...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF00637507

    authors: Lameijer LD,Voermans LA,Houtzagers JJ,Chadha DR

    更新日期:1981-01-01 00:00:00

  • Slower onset of vasodilating action of brain natriuretic peptide (BNP) compared to atrial natriuretic peptide (ANP) in human forearm resistant vessels.

    abstract:PURPOSE:To investigate possible differences in the time course of vasodilating effects of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) in humans. METHODS:We measured forearm blood flow (FBF) by strain gauge plethymography and cyclic GMP spillover during and after intra-arterial infusions of BNP...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/s00228-008-0516-4

    authors: Minami H,Yasu T,Tagawa T,Yamakawa K,Ueda S

    更新日期:2008-09-01 00:00:00

  • The comparative cardiovascular effects of digoxin and food alone and in combination in normal males.

    abstract::The effects of the ingestion of food and digoxin on the cardiovascular system alone and in combination have been observed in eight healthy subjects. A positive inotropic response was seen following food (2.5 MJ) and intravenous digoxin (0.01 mg/kg) with significant decreases in QS2Index (QS2I) pre-ejection period (PEP...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00615959

    authors: Burgess CD,Crane J

    更新日期:1986-01-01 00:00:00

  • A small economic inducement to stimulate increased reporting of adverse drug reactions--a way of dealing with an old problem?

    abstract:PURPOSE:To assess the effect of a small economic inducement on the rate of spontaneous reporting of adverse drug reactions (ADRs) and the attitudes of general practitioners and physicians towards reporting of ADRs. METHOD:One intervention and one control county were selected for the study. Written information about th...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-005-0072-0

    authors: Bäckström M,Mjörndal T

    更新日期:2006-05-01 00:00:00

  • Pharmacodynamics of ticlopidine in man in relation to plasma and blood cell concentration.

    abstract::In 6 normal volunteers given single oral doses of 250,500 and 1000 mg ticlopidine (T), the peak plasma level of unchanged drug was reached after about 2 h. There was no correlation between the plasma T level and its inhibitory effect on platelet function, expressed as % inhibition of ADP-induced aggregation. By means ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00626364

    authors: DiPerri T,Pasini FL,Frigerio C,Blardi P,Centini F,Messa GL,Ghezzi A,Volpi L

    更新日期:1991-01-01 00:00:00

  • Comparison of the pharmacokinetics of glipizide and glibenclamide in man.

    abstract::Four subjects received 5 mg 14C-glipizide orally, 3 subjects 1 mg intravenously and 2 subjects 5 mg 14C-glibenclamide orally. Plasma levels of radioactivity, and urinary and faecal excretion were measured. For both drugs the disappearance of radioactivity from plasma followed complex kinetics and the apparent half-liv...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00616416

    authors: Balant L,Fabre J,Zahnd GR

    更新日期:1975-01-01 00:00:00

  • Pharmacokinetic interaction between indomethacin and diflunisal.

    abstract::The effect of treatment with diflunisal on the steady-state pharmacokinetics of indomethacin has been studied in 16 healthy volunteers. The steady-state plasma concentration and AUC of indomethacin were significantly increased two- to threefold during treatment with diflunisal and its total clearance and total volume ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00558077

    authors: Van Hecken A,Verbesselt R,Tjandra-Maga TB,De Schepper PJ

    更新日期:1989-01-01 00:00:00

  • Pharmacokinetic interactions of almorexant with midazolam and simvastatin, two CYP3A4 model substrates, in healthy male subjects.

    abstract:PURPOSE:Pre-clinical experiments have shown that almorexant, a dual orexin receptor antagonist, is able to inhibit cytochrome P450 3A4 (CYP3A4). Therefore, a study was conducted to investigate the effects of multiple-dose almorexant on the pharmacokinetics of midazolam and simvastatin, two CYP3A4 model substrates. MET...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章,随机对照试验

    doi:10.1007/s00228-012-1403-6

    authors: Hoch M,Hoever P,Alessi F,Theodor R,Dingemanse J

    更新日期:2013-03-01 00:00:00

  • Survival of esophageal and gastric cancer patients with adjuvant and palliative chemotherapy-a retrospective analysis of a register-based patient cohort.

    abstract:PURPOSE:The survival of esophageal and gastric cancer patients treated with chemotherapy is rarely assessed outside of clinical trials. Therefore, we compared the effectiveness of various curative or palliative chemotherapy regimens on the survival of esophageal and gastric cancer patients in a "real world" clinical se...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-020-02883-3

    authors: Ekheden I,Ebrahim F,Ólafsdóttir H,Raaschou P,Wettermark B,Henriksson R,Ye W

    更新日期:2020-07-01 00:00:00

  • Frequency of S-mephenytoin hydroxylation deficiency in 373 Spanish subjects compared to other Caucasian populations.

    abstract::We have investigated the prevalence of poor metabolisers (PM) of S-mephenytoin in 373 unrelated, healthy Spanish Caucasian subjects, based on the enantiomeric S/R mephenytoin ratio in urine collected 0-8 h and 24-32 h after intake of the racemic drug. Five of the subjects were PM (1.34%, 95% confidence interval 0.18-2...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF02440867

    authors: Reviriego J,Bertilsson L,Carrillo JA,Llerena A,Valdivielso MJ,Benítez J

    更新日期:1993-01-01 00:00:00

  • Pharmacokinetics of TZU-0460, a new H2-receptor antagonist, in patients with impaired renal function.

    abstract::We have studied pharmacokinetics of a new H2-receptor antagonist, TZU-0460, in patients with varying degrees of renal impairment. The apparent volume of distribution at steady-state was 1.70 l/kg, and the plasma protein binding of TZU-0460 or its active metabolite, desacetyl TZU-0460 was less than 10% in normal subjec...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00608220

    authors: Takabatake T,Ohta H,Yamamoto Y,Ishida Y,Hara H,Nakamura S,Ushiogi Y,Satoh S,Hattori N

    更新日期:1986-01-01 00:00:00

  • Pharmacokinetic drug interaction between gemfibrozil and sitagliptin in healthy Indian male volunteers.

    abstract:PURPOSE:To study the impact of gemfibrozil co-administration on the pharmacokinetics of sitagliptin in healthy Indian male volunteers. METHODS:A randomized open label two-period crossover study involving 12 healthy Indian male volunteers was conducted at a single center. In each phase, the volunteers were administered...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/s00228-011-1177-2

    authors: K P A,Meda VS,Kucherlapati VS,Dubala A,M D,P R AV,K E,B S

    更新日期:2012-05-01 00:00:00

  • Socio-economic inequalities in first-time use of antidepressants: a population-based study.

    abstract:OBJECTIVE:To analyse whether first-time use of antidepressants (incidence) and selection of TCAs (tricyclic antidepressants) versus new-generation drugs are associated with socio-economic status and psychiatric history. METHOD:We conducted a population-based cohort study using registry data covering Funen County, Denm...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-003-0723-y

    authors: Hansen DG,Søndergaard J,Vach W,Gram LF,Rosholm JU,Mortensen PB,Kragstrup J

    更新日期:2004-03-01 00:00:00

  • Cardiovascular and respiratory effects of the beta-adrenoceptive antagonist sotalol: studies in health, angina pectoris and obstructive lung disease.

    abstract::The cardiovascular and respiratory actions of the adrenergic beta adrenoceptive drug sotalol have been studied in an open, short term trial. Fifteen patients with angina performed standardized orthostatic and exercise tests before and after injection of 20 mg sotalol intravenously. Although there was a significant red...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00562313

    authors: Areskog NH,Cullhed I,Ringqvist I,Ström G

    更新日期:1975-08-14 00:00:00

  • A real or apparent decrease in glomerular filtration rate in patients using olaparib?

    abstract:PURPOSE:Olaparib is a poly (ADP-ribose) polymerase (PARP) inhibitor indicated for ovarian and metastatic breast cancer. Increased serum creatinine levels have been observed in patients taking olaparib, but the underlying mechanism is unknown. This study aimed to investigate if patients receiving olaparib have increased...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-020-03070-0

    authors: Bruin MAC,Korse CM,van Wijnen B,de Jong VMT,Linn SC,van Triest B,Rosing H,Beijnen JH,van den Broek D,Huitema ADR

    更新日期:2021-02-01 00:00:00

  • Effects of angiotensin converting enzyme inhibitor, perindopril, on autonomic reflexes.

    abstract::The effect of the angiotensin converting enzyme inhibitor, perindopril, on autonomic function was assessed in a double blind, placebo controlled, crossover study in 10 normotensive males. Eight milligram of perindopril given orally lowered blood pressure without a change in heart rate. Perindopril enhanced the vagally...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/BF00614298

    authors: Ajayi AA,Lees KR,Reid JL

    更新日期:1986-01-01 00:00:00

  • Efficacy and safety of the 200-300 mg sustained release formulation of diltiazem administered once daily in patients with stable angina.

    abstract::The aim of this multicentre randomised double blind study was to compare the efficacy and safety of the 200-300 mg sustained release diltiazem formulation administered once daily (200-300 SR) with standard diltiazem (D) given three or four times daily to patients with stable angina. Patients aged 59 years, with a repr...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1007/BF00193700

    authors: Trimarco B,Radzik D,Van Mieghem W,Neveux E,Wajman A,Attali P,Ponsonnaille J

    更新日期:1995-01-01 00:00:00

  • Image of systemic antimicrobial agents as perceived by physicians in a 900 bed hospital.

    abstract::A survey among hospital staff physicians was conducted in order to evaluate their attitudes towards systemic antimicrobial agents. Direct questions about the value of different agents and choice within pairs of antimicrobial drugs, stating the reasons for the preference, were included in the questionnaire used. Gentam...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00609876

    authors: Gómez J,Erill S

    更新日期:1979-03-26 00:00:00

  • Nicorandil suppressed myocardial purine metabolism during exercise in patients with angina pectoris.

    abstract::To elucidate the effect of Nicorandil on myocardial energy metabolism and myocardial sympathetic activity, we administered Nicorandil orally to eight patients with angina pectoris prior to exercise testing. Arterial and coronary sinus levels of lactate, ammonia, hypoxanthine (HX), adrenaline and noradrenaline were mea...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00198297

    authors: Ogino K,Osaki S,Noguchi N,Kitamura H,Omodani H,Kato M,Hisatome I,Matsumoto T,Kinugawa T,Miyakoda H

    更新日期:1995-01-01 00:00:00

  • Treatment of acute renal colic in a French emergency department: a comparison of simulated cases and real cases in acute pain assessment and management.

    abstract:OBJECTIVE:Use of analgesic drugs in acute renal colic varies widely in different countries. In order to assess the prescribing patterns in acute renal colic in French emergency departments (EDs), the present study compared intentions of prescription, real prescription and evidence-based data in a sample of emergency pr...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s002280100366

    authors: Jean R,Ducasse JL,Montastruc JL,Lapeyre-Mestre M

    更新日期:2001-11-01 00:00:00

  • Pharmacokinetics and organ distribution of intravenous and oral methylene blue.

    abstract:OBJECTIVE:To determine the pharmacokinetics and organ distribution of i.v. and oral methylene blue, which is used to prevent ifosfamide-induced encephalopathy in oncology. METHODS:The concentration of methylene blue in whole blood was measured using high-performance liquid chromatography in seven volunteers after i.v....

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s002280000124

    authors: Peter C,Hongwan D,Küpfer A,Lauterburg BH

    更新日期:2000-06-01 00:00:00

  • Effect of pregnancy on the pharmacokinetics of caffeine.

    abstract::Individual variation in the half-life of caffeine in the body was measured by HPLC analysis of saliva samples. The mean for adult males and non-pregnant females was 3.4 h (range 2-5 h, n = 25), and 8.3 h (range 3-16 h, n = 57) for pregnant women. After delivery, in most cases the values returned to normal within one m...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00637512

    authors: Knutti R,Rothweiler H,Schlatter C

    更新日期:1981-01-01 00:00:00

  • Relationship between plasma concentrations and pharmacological effects of labetalol.

    abstract::In healthy normal subjects following the administration of labetalol the pharmacological effects were measured and compared with the plasma concentrations achieved. The inhibition of exercise induced tachycardia and inhibition of exercise induced increases in systolic pressure were significantly related to the adminis...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00562897

    authors: Richards DA,Maconochie JG,Bland RE,Hopkins R,Woodings EP,Martin LE

    更新日期:1977-01-03 00:00:00

  • Individualized drug utilization statistics. Analysing a population's drug use from the perspective of individual users.

    abstract::The Danish retail pharmacies' drug subsidy system is completely computerized. The data are person-identifiable, making it possible to chart the population's drug use from the perspective of individual users. We decided to explore the potential of this data source and to analyse heavy drug users specifically. The analy...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00191170

    authors: Hallas J,Nissen A

    更新日期:1994-01-01 00:00:00

  • Pharmacokinetic and pharmacodynamic interactions between the novel calcium sensitiser levosimendan and warfarin.

    abstract:OBJECTIVE:To study the effects of possible interactions between levosimendan and warfarin on pharmacokinetics and pharmacodynamics. Furthermore, the effects of levosimendan on blood coagulation were investigated. METHODS:Open, randomised cross-over design with two treatment phases was used. During one phase, levosimen...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/s002280000204

    authors: Antila S,Jarvinen A,Honkanen T,Lehtonen L

    更新日期:2000-12-01 00:00:00

  • HTR1B as a risk profile maker in psychiatric disorders: a review through motivation and memory.

    abstract:PURPOSE:Serotonin receptor 1B (HTR1B) is involved in the regulation of the serotonin system, playing different roles in specific areas of the brain. We review the characteristics of the gene coding for HTR1B, its product and the functional role of HTR1B in the neural networks involved in motivation and memory; the cent...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章,评审

    doi:10.1007/s00228-009-0724-6

    authors: Drago A,Alboni S,Brunello N,De Ronchi D,Serretti A

    更新日期:2010-01-01 00:00:00

  • Pharmacokinetics of metformin after intravenous and oral administration to man.

    abstract::The kinetics of 14C-metformin have been studied in five healthy subjects after oral and intravenous administration. The intravenous dose was distributed to a small central compartment of 9.9 +/- 1.61 (X +/- SE), from which its elimination could be described using three-compartment open model. The elimination half-life...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00562061

    authors: Pentikäinen PJ,Neuvonen PJ,Penttilä A

    更新日期:1979-09-01 00:00:00

  • In vitro prediction of gastrointestinal absorption and bioavailability: an experts' meeting report.

    abstract::The most convenient route of drug administration is peroral. To reach their target, drug molecules must be absorbed from the gastrointestinal tract and enter the systemic circulation in sufficient quantities. For this reason, understanding and anticipating the mechanisms and factors affecting gastrointestinal absorpti...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章,评审

    doi:10.1007/s002280100369

    authors: Pelkonen O,Boobis AR,Gundert-Remy U,Action COST B15 Working Group 1.

    更新日期:2001-11-01 00:00:00